NICHOLAS MERKIN, Chief Executive Officer, Compliagent.
ANNA M. GRIZZLE, Member , Bass Berry Sims.
2021-11-10
-
Corporate compliance programs may produce data that, in some instances, could be used as evidence of regulatory violations against healthcare organizations and their officers and directors.
-
At the same time, CCOs are bound to obtain and communicate much of that data to relevant stakeholders both inside and outside healthcare organizations as part of effective compliance efforts.
-
Often, evidentiary privileges may protect this information from disclosure. The scope and use of these privileges, however, is often misunderstood. This presentation will explore the application of different privileges within the compliance framework